Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
https://www.zacks.com/stock/news/2215849/merck-mrk-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215849
Jan 25, 2024 - Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Markets Stroll Higher Ahead of Key Data; SMCI, FFIV, WHR Beat
https://www.zacks.com/stock/news/2217484/markets-stroll-higher-ahead-of-key-data-smci-ffiv-whr-beat?cid=CS-ZC-FT-ahead_of_wall_street-2217484
Jan 29, 2024 - A sixth record closing high for the S&P 500 just this month/year alone ought to give a good impression of where the market's collective head is at presently.
0
Home Prices Decreased in November
https://www.zacks.com/stock/news/2218065/home-prices-decreased-in-november?cid=CS-ZC-FT-economic_highlights-2218065
Jan 30, 2024 - Home Prices Decreased in November
0
GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed
https://www.zacks.com/stock/news/2218048/gm-up-on-q4-beat-raise-ups-pfizer-mixed?cid=CS-ZC-FT-ahead_of_wall_street-2218048
Jan 30, 2024 - Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.
0
Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2218071/pfizer-pfe-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2218071
Jan 30, 2024 - While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Pfizer (PFE) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/30/pfizer-pfe-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Jan 30, 2024 - PFE earnings call for the period ending December 31, 2023.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
https://www.fool.com/investing/2024/02/17/is-it-too-late-to-buy-these-2-brilliant-passive-in/?source=iedfolrf0000001
Feb 17, 2024 - Patience will be rewarded with these stocks.
0
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
https://www.fool.com/investing/2024/02/21/these-3-dividend-stocks-yield-more-than-5-but/?source=iedfolrf0000001
Feb 21, 2024 - Relying on payout ratio alone can sometimes give investors a misleading picture of just how safe a dividend payment is.
0
Pfizer (PFE) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2240265/pfizer-pfe-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2240265
Mar 13, 2024 - In the closing of the recent trading day, Pfizer (PFE) stood at $28.22, denoting a +0.75% change from the preceding trading day.
0
Page 1>